ArticlePLoS neglected tropical diseases2026
The role of soluble thrombomodulin (sTM) in risk stratification of hemorrhagic fever with renal syndrome and prognostic assessment.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The Changing Landscape of Hantavirus Infections: A Narrative Review of Epidemiology, Pathogenesis, and Countermeasures.Reviews in medical virology · 2026Review
- Orthohantavirus Infection Mimicking Acute Viral Hepatitis: An Underrecognized Clinical Presentation.Pathogens (Basel, Switzerland) · 2026Review
- Bile acid signaling at the gut-vascular interface: a novel modulator of hantavirus endothelial barrier dysfunction.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe increase in vascular permeability and bleeding caused by systemic endothelial damage is the most basic pathological change of hemorrhagic fever with renal syndrome(HFRS) caused by Hantavirus, but there is a lack of early biomarkers to detect the severity and prognosis of HFRS. Soluble thrombomodulin (sTM) is a sensitive marker of endothelial damage. In this study we investigated the role of sTM in the evaluation of the severity and prognosis of HFRS patients.
methodsA retrospective analysis was conducted on 51 patients with HFRS treated in the Infectious Diseases Department of the Second Affiliated Hospital of Air Force Medical University from January 2023 to January 2024. We compared the changes of sTM among patients with HFRS in different phases and subtypes, and analyzed the correlation between sTM and related laboratory diagnostic indicators. Additionally, we evaluated the differences of sTM and related laboratory diagnostic indicators between survivors and non-survivors, and assessed the predictive ability of sTM for the mortality risk of HFRS patients based on the ROC curve, and determined the cut-off value of sTM.
resultsIn the HFRS phases, sTM increased during the febrile phase, reached its peak during the hypotensive phase, and decreased during the oliguria-dipuria phase. In the HFRS subtypes, there was no difference between the mild and moderate subtypes (P > 0.05), while in the moderate, severe, and critical subtypes, it showed a "stepwise" increase (P < 0.05), with the greatest jump being from "severe" to "critical" (P < 0.0001). Linear regression analysis revealed a strong positive correlation between sTM and SOFA scores (R² = 0.6076, P < 0.0001). The level of sTM in the non-survivor group (62.25 (54.60, 81.98) TU/mL) was significantly higher than that in the survivor group (28.10 (21.40, 44.15) TU/mL). The ROC curve indicated that the AUC of sTM was 0.9317, which had a high predictive value for the mortality risk of HFRS patients and was second only to SOFA (0.9309), and the combined AUC could reach 0.9492. When the cut-off of sTM was 49.98 TU/mL, the sensitivity and specificity were 81.36% and 100%. In addition, the Kaplan-Meiers survival analysis showed that when sTM ≥ 49.8 TU/mL, the 28-day mortality rate of HFRS patients was higher (P < 0.01).
conclusionsTM serves as a valuable biomarker for risk stratification and prognosis evaluation in HFRS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.